Results

Disease-free rate (%)

Metastasis-free survival rate (%)

Overall survival rate (%)

Stages Ia, Ib, Ic

95% at 4 years

95% at 4 years

95% at 4 years

Stages IIIa, IIIb, IIIc

96.4% at 5 years

95% at 4 years

95% at 4 years

All groups

96.9% at 5 years

96.9% at 5 years

96.9% at 5 years